French Pharma To Give US “Preference” On Vaccine

Bloomberg News reports:

Americans will likely get Sanofi’s Covid-19 vaccine before the rest of the world if the French pharmaceutical giant can successfully deliver one.

That’s because the U.S. was first in line to fund Sanofi’s vaccine research, Chief Executive Officer Paul Hudson said in an interview with Bloomberg News. He warned that Europe risks falling behind unless it steps up efforts to seek protection against a pandemic that’s killed more than 290,000 people worldwide.

“The U.S. government has the right to the largest pre-order because it’s invested in taking the risk,” Hudson said. The U.S., which expanded a vaccine partnership with the company in February, expects “that if we’ve helped you manufacture the doses at risk, we expect to get the doses first.”

Read the full article.

LATEST: Americans will get Sanofi’s Covid-19 vaccine before the rest of the world if the French pharmaceutical giant can successfully deliver one https://t.co/VahjzsaEzY

— Bloomberg (@business) May 13, 2020